Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David Y. Liu is active.

Publication


Featured researches published by David Y. Liu.


Atherosclerosis | 2001

Inhibition of the mitogen activated protein kinase, p38α, prevents proinflammatory cytokine induction by human adherent mononuclear leukocytes in response to lipid loading

Ying Feng; George F. Schreiner; Sarvajit Chakravarty; David Y. Liu; Alison Joly

Macrophage infiltration, inflammatory processes and oxidatively modified low density lipoprotein (LDL) are known contributing factors in the formation of the atherosclerotic plaque. To determine whether a direct link might exist between these factors, we examined the effect of oxidized LDL upon proinflammatory cytokine production in adherent human peripheral blood mononuclear leukocytes. Oxidized LDL, as well as a combination of cholesterol and 25-hydroxycholesterol, induced tumor necrosis factor-alpha (TNFalpha) and interleukin-1 beta (IL-1 beta) mRNA as measured by quantitative real time PCR, by a maximum of two- to fourfold following a 24-h incubation. Analysis of cell culture supernatants revealed a concomitant stimulation of TNFalpha and IL-1 beta secreted protein as determined by ELISA. Treatment of human peripheral blood mononuclear leukocytes with oxidized LDL or the combination of cholesterol and 25-hydroxycholesterol caused activation of p38 alpha as determined by the ability of immunoprecipitated p38 to phosphorylate an ATF-2 fusion protein, a surrogate substrate of p38 alpha. VK-19911 (Pyridine, 4-[4-(4-fluorophenyl)-1-(4-piperidinyl)-1H-imidazol-5-yl]-dihydrochloride), a specific inhibitor of p38 alpha, prevented the induction of TNFalpha and IL-1 beta by oxidized LDL in a dose-dependent manner. Activated p38 alpha is known to be involved in the stabilization of cyclooxygenase-2 mRNA in response to stimuli such as lipopolysaccharide; however, in the setting of oxidized LDL-induced p38 alpha activation, COX-2 mRNA levels were not affected. Taken together, the data imply a potential role for p38 alpha activation in lipid-associated inflammatory processes.


Archive | 1999

Quinazoline derivatives as medicaments

Sarvajit Chakravarty; Sundeep Dugar; John J. Perumattam; George F. Schreiner; David Y. Liu; John A. Lewicki


Archive | 1999

Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase

R. Richard Goehring; Gregory R. Luedtke; Babu J. Mavunkel; Sarvajit Chakravarty; Sundeep Dugar; George F. Schreiner; David Y. Liu; John A. Lewicki


Archive | 2000

Compounds and methods to treat cardiac failure and other disorders

Babu J. Mavunkel; David Y. Liu; George F. Schreiner; John A. Lewicki; John J. Perumattam


Archive | 2001

Inhibitors of p38-a kinase

R. Richard Goehring; Babu J. Mavunkel; David Y. Liu; George F. Schreiner; Gregory Leudtke; John A. Lewicki


Archive | 2003

Treatment of fibroproliferative disorders using TGF-beta inhibitors

Sarvajit Chakravarty; Sundeep Dugar; Linda S. Higgins; Ann M. Kapoun; David Y. Liu; Andrew Asher Protter; George F. Schreiner; Thomas-Toan Tran


Archive | 1999

Heterocyclic compounds and methods to treat cardiac failure and other disorders

Babu J. Mavunkel; David Y. Liu; George F. Schreiner; John A. Lewicki; John J. Perumattam


Archive | 2004

Treatment of malignant gliomas with TGF-beta inhibitors

Michael Weller; Sundeep Dugar; Linda S. Higgins; David Y. Liu; George F. Schreiner; Sarvajit Chakravarty


Archive | 2003

Methods for improvement of lung function using tgf-beta inhibitors

Zhihe Li; David Y. Liu; Jing Ying Ma; Andrew A. Protter; George F. Schreiner; Thomas-Toan Tran


Archive | 1998

Quinazoline derivatives as inhibitors of P-38 α

Sarvajit Chakravarty; John J. Perumattam; George F. Schreiner; David Y. Liu; John A. Lewicki

Collaboration


Dive into the David Y. Liu's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sarvajit Chakravarty

University of Medicine and Dentistry of New Jersey

View shared research outputs
Top Co-Authors

Avatar

Sundeep Dugar

University of Medicine and Dentistry of New Jersey

View shared research outputs
Top Co-Authors

Avatar

Linda S. Higgins

University of Medicine and Dentistry of New Jersey

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ying Feng

BioMarin Pharmaceutical

View shared research outputs
Top Co-Authors

Avatar

Alison Joly

Samsung Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge